Stocktoria
vTv Therapeutics Inc. VTVT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-07-30
vTv Therapeutics Inc. statistics & valuation
Market cap$127.0M
P / B2.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -2377.6% | — | -1116.9% | -540.9% |
| Net margin | — | -1815.3% | — | -949.7% | -324.3% |
| FCF margin | — | -2488.4% | — | -795.0% | -482.1% |
| Return on assets | -30.0% | -48.2% | -183.8% | -57.7% | -51.0% |
| Return on equity | -41.9% | -129.1% | 82.1% | 178.4% | 133.3% |
| Current ratio | 13.54 | 7.34 | 1.00 | 3.52 | 1.84 |
| Revenue growth | -100.0% | — | -100.0% | -49.6% | -37.6% |
Source: SEC EDGAR filings · CIK 0001641489 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.